JERUSALEM, March 15, 2021 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") announced today that it has entered into a definitive agreement for a business combination with ...

Intec Pharma, which is developing an improved delivery method of carbidopa/levodopa for Parkinson's disease, filed on Tuesday with the SEC to raise up to $46 million in a US initial public offering.

Intec Pharma ($NTEC) has raised $30 million (€28 million) in an IPO on Nasdaq. The haul is down on the most recent target--and represents a discount on its share ...

A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment ...

JERUSALEM, Oct. 29, 2020 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces a 1-for-20 reverse share split of its outstanding ordinary shares. The reverse ...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining exploration companies often lose money for years before finding success with a new ...

JERUSALEM & MONTREAL--(BUSINESS WIRE)--June 15, 2006--Intec Pharma, developer of the Accordion Pill(TM) gastric retention technology, announced today that it has entered into an agreement with two ...

NEW YORK, March 26, 2021 /PRNewswire/ — Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class ...